Newly-released bioactive materials industry analysis by Fact.MR reveals that global revenue from bioactive materials in 2020 was US$ 2 Bn. The industry is likely to expand at a projected CAGR of 11.3% during 2021 – 2031. Bioactive composite materials are expected to be the highest revenue generating segment, accounting for an absolute dollar opportunity of nearly US$ 1.7 Bn over the next ten years.
Key Points Covered in Bioactive Materials Industry Survey:
- Market Estimates and Forecasts (2016-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Assessment of Import Price, Bulk Price, Contractual Price, Producer / Distributor Price
- Market Share Analysis
- Assessment by Product Grade / Purity / Formulation Standards
- COVID-19 Impact on Demand for Bioactive Materials and How to Navigate
- Recommendation on Key Winning Strategies
Know More Details About the Report
Consumption Analysis of Bioactive Materials from 2016 to 2020 Compared to Demand Outlook for 2021 to 2031
As per the bioactive materials industry research by Fact.MR - a market research and competitive intelligence provider, historically, from 2016 to 2020, market value of the bioactive materials industry increased at around 9.9% CAGR, where revenue was largely dominated by countries such as the U.S., Germany, U.K., China, and Japan.
In the recent past, age-related pathologies have mushroomed along with the aging population. This has created significant increase in demand for bioactive materials to repair age-borne damaged tissues.
Bioactive scaffolds display high efficiency in tissue repair, and their high mechanical efficiency, biocompatibility, and load-bearing capabilities makes them suitable for regenerative medicine applications. Besides these characteristics, they are also promising for soft tissue engineering.
With these dynamics, demand for bioactive materials is projected to increase at a CAGR of 11.3% over the coming 10 years.
- The bioactive materials market reached a valuation of US$ 2 Bn in 2020, while demand witnessed low, though positive growth amid the COVID-19 pandemic.
- Fact.MR estimates that bioactive materials revenue will grow 2.9X from 2021 to 2031, reaching nearly US$ 6.2 Bn in 2031.
- Revenue from bioactive composite materials will account for over 40% share, owing to their suitability for skin tissue engineering and cardiovascular tissue repair.
- Revenue from moldable bioactive materials is expected to grow 190 BPS during the forecast period.
- Bioactive material demand in bioengineering applications is projected to grow 3X by 2031.
- Top 5 providers of bioactive materials held around 23% market share in 2020.
Bioactive Material: Prospective Candidate for In-situ Drug Delivery Models – What is the Reality?
Bioactive materials have been studied for a considerable time for in-situ drug delivery. Through the usage of bioactive materials, alongside favouring tissue regrowth, peri-implant traumas can also be avoided.
Recent researches on nano-science impart strong indication about the applicability of bioceramics in drug delivery of antibiotic, anti-osteoporotic, and anticancer compounds, owing to their carrier suitability.
Considering these implications, bioactive material sales are expected to cross the US$ 6 Bn mark by 2031.
Avail customized purchase options for your needs
From Medical Applications to Food Preservation, How are Bioactive Materials Suited for New Applications?
Owing to their characteristics, biomaterials have started to find use across new applications. Quebec, in Canada, produces significant volumes of strawberries, though considering the vulnerability of the fruit, they need proper packaging.
In 2021, Monique Lacroix, a professor at the Institut national de la recherche scientifique, along with her team, developed a bioactive packaging film that keeps strawberries fresh for nearly 12 days. This packaging also hasantimicrobial properties, which makes it further suited for this application.
In another instance, the BioActiveMaterials project conducted by researchers at Fraunhofer-Gesellschaft, led to the development of an eco-friendly coating for paper packaging. When put into application, not only is plastic saved, but the coating of plant-based proteins and waxes also extends the shelf life of the food.
While it will be too early to comment on the commercial scale viability of bioactive materials for food, it is indicative of their open prospects in newer applications.
Which Region Accounts for the Largest Demand for Bioactive Materials?
With an absolute dollar opportunity of US$ 1.2 Bn, North America would remain the most lucrative region for bioactive material manufacturers. The key reason for the highest market share is it highly developed healthcare sector.
The dentistry industry in both, the U.S. and Canada is advanced, and uses advanced technologies. The North American dental consumables market stood at US$ 7 Bn in in 2020. Besides, population to dentist ratio in the region has also been on the rise. Dentistry, being one of the core application areas of bioactive materials, is expected to offer significant opportunities over the coming years.
An Adaptive Approach to Modern-day Research Needs
Which Country is Projected to Offer the Largest Opportunity for Bioactive Material Manufacturers?
There has been significant rise in oral cancer cases in China in the recent past, which has led to demand explosion of advanced dentistry and oral care products, including bioactive materials.
According to BMC Oral Health, between 1990 and 2017, total number of oral cancer cases in China increased 280% and 79.7% for new cases and age-based incidence, respectively. This took the number of deaths and age-based mortality at 196.8% and 29%, respectively, in the country.
According to The Cancer Registry Report, published by the National Central Cancer Registry of China, in 2015, there were about 4.3 Mn new cancer cases and 2.8 Mn cancer deaths in China. Out of this, nearly 48,100 new cases and 22,100 deaths were caused due to oral and oropharyngeal cancer, which accounted for 1.1% and 0.8% of all new cancer cases and deaths, respectively.
Owing to these alarming numbers, the country has been gearing up for advanced technologies in dentistry, and consequently, demand growth for bioactive materials of over 13% can be expected in China over the next ten years.
Which Bioactive Material Accounts for the Largest Revenue Share?
Bioactive composite materials accounted for over 40% revenue of the market in 2020. The capability of bioactive composite materials to regenerate dental hard tissues makes them a preferred choice.
Why are Powdered Bioactive Materials Preferred for Biomedical Applications?
Powdered bioactive materials accounted for over 40% bioactive material revenue in 2020.
Biomedical applications, including tissues, scaffolds, and fixation devices need specific fabrication. Thus, the process, without rigid support structures is recommended, which involves the use of imprinted powders that support complex parts during the printing process.
How Has COVID-19 Impacted Revenue Generation from Bioactive Materials?
Revenue from bioactive materials witnessed slow growth with the onset of the COVID-19 pandemic, though growth remained positive.
As compared to nearly 12% year-on year market growth in 2019, demand grew by around 5% in 2020. Since, most of the applications of bioactive materials fall under the healthcare category, their manufacturing was less impacted with lesser restrictions being imposed on this sector.
Have a report related query? Speak to us directly
According to market research analysis, partnerships and product developments featured among the key developments in the global bioactive materials market.
Recent developments by key bioactive material providers are as follows:
- In July 2021, Arthrex announced distribution agreement with Celularity under which the former will receive rights for distribution and commercialization of Celularity’s biomaterial products for orthopaedics and sports medicine that are placental-derived.
- In June 2021, Lineage Cell Therapeutics, Inc. announced it granted an option to Amasa Therapeutics, Inc., a biopharmaceutical company, to acquire a royalty-bearing license to utilize HyStem technology of Lineage Cell Therapeutics for the development and marketing of therapies for treatment of solid tumors under pre-negotiated terms.
Similarly, recent developments related to companies offering bioactive materials have been tracked by the team at Fact.MR, which are available in the full report.
Bioactive Materials Market Report Scope
Historical Data Available for
|US$ Mn for Value|
Key Regions Covered
Key Countries Covered
Key Market Segments Covered
Key Companies Profiled
Available upon Request
Market Segments Covered in Bioactive Materials Industry Analysis
- Bioactive Glass
- Bioactive Glass Ceramic
- Bioactive Composite Material
- Other Bioactive Materials
- Powdered Bioactive Materials
- Moldable Bioactive Materials
- Granulated Bioactive Materials
- Injectable Bioactive Materials
- Bioactive Materials for Dentistry
- Bioactive Materials for Surgery
- Bioactive Materials for Bioengineering
- Bioactive Materials for Other Applications
Bioactive Materials Market- Scope of Report
A recent study by Fact.MR on the bioactive materials market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with the development of bioactive materials.
The study also provides the dynamics that are responsible for influencing the future status of the market over the forecast period. A detailed assessment of value chain analysis, business execution, cost structure analysis, and supply chain analysis across regional markets has been covered in the report.
A list of prominent companies manufacturing bioactive materials, along with their product portfolios, enhances the reliability of this comprehensive research study.
The study offers comprehensive analysis on diverse features, including production capacities, product developments, revenue generation, and sales of bioactive materials across the globe.
A comprehensive estimate on the market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of bioactive materials during the forecast period.
Analysis on Market Size Evaluation
The market has been analyzed for each market segment in terms of value (US$ Mn). Market estimates at global and regional levels for bioactive materials are available in terms of “US$ Mn”. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a solution provider can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global bioactive materials market.
Inspected Assessment on Regional Segments
Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include Porter’s five forces analysis and PESTLE analysis (political, economic, social, technology, legal, and environment outlook), which are expected to have a momentous influence on the growth of the bioactive materials market during the forecast period.
Country-specific valuation on demand for bioactive materials has been offered for each regional market, along with market scope estimates and forecasts, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value for emerging countries has also been included in the report.
In-depth Competition Analysis
The report sheds light on leading manufacturers of bioactive materials, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the manufacturing of bioactive materials has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the bioactive materials market.
- FAQs -
The global bioactive materials market is worth US$ 2 Bn at present.
Value sales of bioactive materials are projected to increase at a CAGR of around 11.3% during 2021 – 2031.
Value sales of bioactive materials increased at a CAGR of around 9.9% during 2016 – 2020.
Growing research on making bioactive materials suitable for food packaging is one of the concurrent trends in the bioactive materials industry.
Up-gradation of healthcare infrastructure across key countries has been the foremost driver for bioactive materials sales.
According to ratings on the basis of market share, market reach, clientele, etc., top 5 manufacturers of bioactive materials account for around 23% share in the global market.
Top 5 countries driving demand for bioactive materials are the U.S., Germany, U.K., China, and Japan.
North America accounted for over 38% of global bioactive materials revenue in 2020.
The European market for bioactive materials is projected to surge at a CAGR of around 11.5% during 2021 – 2031.
While the market in China is expected to expand at 13.4% CAGR, demand in Japan is projected to register a CAGR of 12.8% during 2021 - 2031.
Need an Exclusive Report for your Unique Requirement?
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.